Background: The inappropriate usage of terms and concepts and/or unclear definitions provided in the scientific literature hinder progress in any scientific field. This risk is especially noticeable in applied fields of research such as sports science and physical education. Objective: This study explored existing literature that uses the term ‘motor performance skills’ and aimed to propose a comprehensive definition to be applied in future research. Method: Following an adapted scoping approach grounded in the rapid review model, we searched electronic databases Pub-Med/Medline, Web of Science, and Scopus until February 2022. The primary demographic focus was sports science and physical education disciplines. After screening of titles and abstracts, 184 papers were identified for a full review. Twenty-two papers met the inclusion criteria from the full review and received qualitative content analysis. The qualitative content analysis focused on the elaborated qualities of the term ‘motor performance skill’. Coding was used to identify and extract content, identify patterns, and observe the depth of interpretation of the term. Results: Only six papers used descriptive language, and three used explanatory language to convey aspects of the term’s meaning. All included papers extrapolated or provided examples to demonstrate the term’s meaning. Based on a collaborative process, the study reached a proposed definition that has the potential to be coined for the term ‘motor performance skills’ and used in future research. Conclusion: Thus, the current analysis revealed the need to collaboratively address the conceptual ambiguity and develop a comprehensive definition of ‘motor performance skills’

No abstract

Background: Obesity has been identified as a global epidemic that is associated with numerous comorbidities such as type 2 diabetes, hypertension, cancer, cardiovascular disease. We have investigated the effects of Watsu® therapy and Immersion on HRV parameters of obese male subjects. Methods and Results:Volunteer 34 obese subjects with BMI above 30 without any other chronic health issues were included (age, 18.30±.31, height, 166.02±29.60, BMI, 36.54±5.96). Randomized controlled trial was conducted with Watsu and Immersion protocols whereas control group received no therapy in water or on land for 12 weeks. A baseline HRV was recorded 5 minutes in four different circumstances. Polar H7 heart rate sensor and digital standardized HRV signal processing software were used to record the R-R intervals in millisecond. The repeated measures were used to compare the conditions between the therapies. The HRV analyses were performed using three-way Mixed ANOVA. Multiple comparisons were done with a Bonferroni adjustment of the alpha level (0.05). The collective results of HF showed significant negative effect (13.01±1.36, 9.99±1.11) and HF laying supine value (20.62±2.22) was the highest (p<0.05).Conclusion: A significant inverse correlation was found between HRV values and both therapeutic interventions. Counterintuitively, 12-week of watsu and immersion therapies decreased LF and HF.

No abstract

The purpose of this study was to compare the effects of Immersion and Watsu® therapy protocols on children with cerebral palsy. Gross motor function (GMF), spasticity (MAS), and Quality of Life (QoL) parameters of twenty-three children (age: 7.5±2.8, BMI: 17±3.7) were measured. Subjects received Watsu® therapy and Immersion protocols in Watsu-Immersion (W-I, n=12) and Immersion-Watsu (I-W n=11) groups in different periods based on a crossover design. The subjects received sessions for 30 minutes twice a week during 10-week experimental periods. The results were investigated with independent sample t-test and Wilcoxon rank-sum tests, which showed that there was no evidence of carryover effects in GMFM 88 and QoL. In contrast, Watsu® improved GMFM 88 (p<0.05), Quality of Life (p<0.05), and MAS-Upper spasticity (p<0.05), scores significantly compared to immersion. The current results demonstrated the specific benefits of Watsu® therapy on children with CP, confirming the previous anecdotal reports. We recommend Watsu® as a safe and well-accepted complementary intervention for the management of CP.